Advertisement
Screener

BIONIK LABORATORIES CORP. Goodwill, Impairment Loss

BIONIK LABORATORIES CORP. Goodwill, Impairment Loss

BIONIK LABORATORIES CORP. reported Goodwill, Impairment Loss of $4.28 million for the 12-month period ending 2022-03-31, per its 10-K filed 2023-06-21.

Discontinued › Expense Statement › Operating Expenses

us-gaap:GoodwillImpairmentLoss · last filed 2023-06-21

  • BIONIK LABORATORIES CORP. goodwill, impairment loss for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
  • BIONIK LABORATORIES CORP. goodwill, impairment loss for the quarter ending 2021-03-31 was $3.00K.
  • BIONIK LABORATORIES CORP. goodwill, impairment loss for fiscal 2022 was $4.28M, a 37.04% decline from fiscal 2021.
  • BIONIK LABORATORIES CORP. goodwill, impairment loss for fiscal 2021 was $6.80M, a 39.38% decline from fiscal 2020.
  • BIONIK LABORATORIES CORP. goodwill, impairment loss for fiscal 2020 was $11.22M.
  • BIONIK LABORATORIES CORP. goodwill, impairment loss for fiscal 2019 was $0.00.
Period endGoodwill, Impairment Loss 3 monthGoodwill, Impairment Loss 9 monthGoodwill, Impairment Loss 12 monthGoodwill, Impairment Loss 12 month as first filed
2022-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21
$4.28M
10-K · filed 2023-06-21
2021-12-31$4.28M
10-Q · filed 2022-02-09
2021-03-31$3.00K
derived: 10-K 12 month − 10-K 9 month · filed 2022-06-09
$6.80M
10-K · filed 2022-06-09
$6.80M
10-K · filed 2021-06-24
2020-12-31$6.80M
10-K · filed 2021-06-24
2020-03-31$11.22M
10-K · filed 2020-06-29
2019-03-31$0.00
10-K · filed 2020-06-29